Janssen Pharmaceuticals, Inc.

Registered sites: 0
Drug products: 149
Live patents: 232
Countries: 0
Base: Unknown

Sites

Facilities

No registered facilities

This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.

Alert

Products in shortage

Drug	Presentation	Availability
Methylphenidate Hydrochloride Tablet, Extended Release	Concerta, Tablet, Extended Release, 36 mg (NDC 50458-586-01)	Available
Methylphenidate Hydrochloride Tablet, Extended Release	Concerta, Tablet, Extended Release, 27 mg (NDC 50458-588-01)	Available
Methylphenidate Hydrochloride Tablet, Extended Release	Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01)	Available
Methylphenidate Hydrochloride Tablet, Extended Release	Concerta, Tablet, Extended Release, 54 mg (NDC 50458-587-01)	Available

Exclusivity

Patents

232

Unexpired Orange Book patents where this company is the application holder.

Product	Active ingredient	Expiry
AKEEGA	ABIRATERONE ACETATE; NIRAPARIB TOSYLATE	Aug 2027
AKEEGA	ABIRATERONE ACETATE; NIRAPARIB TOSYLATE	Apr 2029
AKEEGA	ABIRATERONE ACETATE; NIRAPARIB TOSYLATE	Mar 2031
AKEEGA	ABIRATERONE ACETATE; NIRAPARIB TOSYLATE	Aug 2031
AKEEGA	ABIRATERONE ACETATE; NIRAPARIB TOSYLATE	Jul 2037
AKEEGA	ABIRATERONE ACETATE; NIRAPARIB TOSYLATE	Mar 2038
BALVERSA	ERDAFITINIB	Apr 2031
BALVERSA	ERDAFITINIB	Apr 2033
BALVERSA	ERDAFITINIB	Mar 2035
BALVERSA	ERDAFITINIB	Oct 2035
BALVERSA	ERDAFITINIB	Feb 2036
BALVERSA	ERDAFITINIB	Jun 2036
BALVERSA	ERDAFITINIB	Aug 2036
BALVERSA	ERDAFITINIB	Feb 2038
EDURANT PED	RILPIVIRINE HYDROCHLORIDE	Oct 2037
ERLEADA	APALUTAMIDE	Mar 2027
ERLEADA	APALUTAMIDE	Feb 2032
ERLEADA	APALUTAMIDE	Jun 2033
ERLEADA	APALUTAMIDE	Sept 2033
ERLEADA	APALUTAMIDE	Dec 2035
ERLEADA	APALUTAMIDE	Apr 2038
ERLEADA	APALUTAMIDE	Jan 2040
ERLEADA	APALUTAMIDE	Jan 2041
ICOTYDE	ICOTROKINRA HYDROCHLORIDE	Jul 2039
ICOTYDE	ICOTROKINRA HYDROCHLORIDE	Jan 2041
ICOTYDE	ICOTROKINRA HYDROCHLORIDE	Nov 2041
INLEXZO	GEMCITABINE HYDROCHLORIDE	Jun 2030
INLEXZO	GEMCITABINE HYDROCHLORIDE	Dec 2030
INLEXZO	GEMCITABINE HYDROCHLORIDE	Apr 2032
INLEXZO	GEMCITABINE HYDROCHLORIDE	Aug 2034
INLEXZO	GEMCITABINE HYDROCHLORIDE	Nov 2038
INVEGA HAFYERA	PALIPERIDONE PALMITATE	May 2041
INVEGA HAFYERA	PALIPERIDONE PALMITATE	Nov 2041
INVEGA SUSTENNA	PALIPERIDONE PALMITATE	Jan 2031
INVEGA TRINZA	PALIPERIDONE PALMITATE	Apr 2036
INVOKAMET	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	Jul 2027
INVOKAMET	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	Dec 2027
INVOKAMET	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	Jan 2028
INVOKAMET	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	Jun 2028
INVOKAMET	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	Feb 2029
INVOKAMET	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	Aug 2029
INVOKAMET	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	Jul 2030
INVOKAMET XR	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	Jul 2027
INVOKAMET XR	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	Dec 2027
INVOKAMET XR	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	Jan 2028
INVOKAMET XR	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	Jun 2028
INVOKAMET XR	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	Feb 2029
INVOKAMET XR	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	Aug 2029
INVOKANA	CANAGLIFLOZIN	Jul 2027
INVOKANA	CANAGLIFLOZIN	Dec 2027
INVOKANA	CANAGLIFLOZIN	Jan 2028
INVOKANA	CANAGLIFLOZIN	Jun 2028
INVOKANA	CANAGLIFLOZIN	Feb 2029
INVOKANA	CANAGLIFLOZIN	Aug 2029
LAZCLUZE	LAZERTINIB MESYLATE	Oct 2035
LAZCLUZE	LAZERTINIB MESYLATE	Apr 2038
LAZCLUZE	LAZERTINIB MESYLATE	May 2040
LAZCLUZE	LAZERTINIB MESYLATE	May 2040
LAZCLUZE	LAZERTINIB MESYLATE	Apr 2041
LAZCLUZE	LAZERTINIB MESYLATE	Aug 2041

Catalogue

Marketed products

149

Showing 149 of 149.

Brand	Generic name	Form	Category
AKEEGA	NIRAPARIB TOSYLATE MONOHYDRATE and ABIRATERONE ACETATE	TABLET, FILM COATED	NDA
AKEEGA	NIRAPARIB TOSYLATE MONOHYDRATE and ABIRATERONE ACETATE	TABLET, FILM COATED	NDA
-	Abiraterone Acetate	POWDER	BULK INGREDIENT
-	Apalutamide	POWDER	BULK INGREDIENT
BALVERSA	Erdafitinib	TABLET, FILM COATED	NDA
BALVERSA	Erdafitinib	TABLET, FILM COATED	NDA
BALVERSA	Erdafitinib	TABLET, FILM COATED	NDA
-	Buprenorphine	POWDER	BULK INGREDIENT
-	Buprenorphine Hydrochloride	POWDER	BULK INGREDIENT
CARVYKTI	ciltacabtagene autoleucel	INJECTION, SUSPENSION	BLA
CONCERTA	Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	NDA
CONCERTA	Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	NDA
CONCERTA	Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	NDA
CONCERTA	Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	NDA
-	Canagliflozin	POWDER	BULK INGREDIENT
-	Canagliflozin	POWDER	BULK INGREDIENT
DARZALEX	Daratumumab	INJECTION, SOLUTION, CONCENTRATE	BLA
Darzalex Faspro	daratumumab and hyaluronidase-fihj (human recombinant)	INJECTION	BLA
Darzalex IV	Daratumumab	INJECTION, SOLUTION, CONCENTRATE	BLA
EDURANT	rilpivirine hydrochloride	TABLET, FILM COATED	NDA
EDURANT PED	rilpivirine hydrochloride	TABLET, FOR SUSPENSION	NDA
ELMIRON	PENTOSAN POLYSULFATE SODIUM	CAPSULE, GELATIN COATED	NDA
ERLEADA	Apalutamide	TABLET, FILM COATED	NDA
ERLEADA	Apalutamide	TABLET, FILM COATED	NDA
-	Galantamine hydrobromide	POWDER	BULK INGREDIENT
Haldol Decanoate	Haloperidol Decanoate	INJECTION	NDA
Haldol Decanoate	Haloperidol Decanoate	INJECTION	NDA
-	Haloperidol	POWDER	BULK INGREDIENT
ICOTYDE	icotrokinra	TABLET, FILM COATED	NDA
IMAAVY	nipocalimab-aahu	INJECTION, SOLUTION, CONCENTRATE	BLA
IMAAVY	nipocalimab-aahu	INJECTION, SOLUTION, CONCENTRATE	BLA
INFLIXIMAB	INFLIXIMAB	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	BLA
INLEXZO	gemcitabine intravesical	SYSTEM	NDA
INVEGA	paliperidone	TABLET, EXTENDED RELEASE	NDA
INVEGA	paliperidone	TABLET, EXTENDED RELEASE	NDA
INVEGA	paliperidone	TABLET, EXTENDED RELEASE	NDA
INVEGA	paliperidone	TABLET, EXTENDED RELEASE	NDA
INVEGA HAFYERA	paliperidone palmitate	INJECTION, SUSPENSION, EXTENDED RELEASE	NDA
INVEGA HAFYERA	paliperidone palmitate	INJECTION, SUSPENSION, EXTENDED RELEASE	NDA
INVEGA SUSTENNA	paliperidone palmitate	INJECTION	NDA
INVEGA SUSTENNA	paliperidone palmitate	INJECTION	NDA
INVEGA SUSTENNA	paliperidone palmitate	INJECTION	NDA
INVEGA SUSTENNA	paliperidone palmitate	INJECTION	NDA
INVEGA SUSTENNA	paliperidone palmitate	INJECTION	NDA
INVEGA TRINZA	paliperidone palmitate	INJECTION, SUSPENSION, EXTENDED RELEASE	NDA
INVEGA TRINZA	paliperidone palmitate	INJECTION, SUSPENSION, EXTENDED RELEASE	NDA
INVEGA TRINZA	paliperidone palmitate	INJECTION, SUSPENSION, EXTENDED RELEASE	NDA
INVEGA TRINZA	paliperidone palmitate	INJECTION, SUSPENSION, EXTENDED RELEASE	NDA
INVOKAMET	canagliflozin and metformin hydrochloride	TABLET, FILM COATED	NDA
INVOKAMET	canagliflozin and metformin hydrochloride	TABLET, FILM COATED	NDA
INVOKAMET	canagliflozin and metformin hydrochloride	TABLET, FILM COATED	NDA
INVOKAMET	canagliflozin and metformin hydrochloride	TABLET, FILM COATED	NDA
INVOKAMET XR	canagliflozin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	NDA
INVOKAMET XR	canagliflozin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	NDA
INVOKAMET XR	canagliflozin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	NDA
INVOKAMET XR	canagliflozin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	NDA
INVOKANA	canagliflozin	TABLET, FILM COATED	NDA
INVOKANA	canagliflozin	TABLET, FILM COATED	NDA
-	Icotrokinra	POWDER	BULK INGREDIENT
Intelence	etravirine	TABLET	NDA
Intelence	etravirine	TABLET	NDA
Intelence	etravirine	TABLET	NDA
-	Itraconazole	POWDER	BULK INGREDIENT
LAZCLUZE	lazertinib	TABLET, FILM COATED	NDA
LAZCLUZE	lazertinib	TABLET, FILM COATED	NDA
-	Loperamide hydrochloride	POWDER	BULK INGREDIENT
-	Mebendazole	POWDER	BULK INGREDIENT
-	Miconazole Nitrate	POWDER	BULK INGREDIENT
-	POLYETHYLENE GLYCOL 400	SOLUTION	DRUG FOR FURTHER PROCESSING
-	POLYETHYLENE GLYCOL 400	SOLUTION	DRUG FOR FURTHER PROCESSING
PONVORY	Ponesimod	KIT	NDA
PONVORY	Ponesimod	TABLET, FILM COATED	NDA
PREZCOBIX	DARUNAVIR ETHANOLATE and COBICISTAT	TABLET, FILM COATED	NDA
PREZCOBIX	DARUNAVIR ETHANOLATE and COBICISTAT	TABLET, FILM COATED	NDA
PREZCOBIX PED	DARUNAVIR ETHANOLATE and COBICISTAT	TABLET, FOR SUSPENSION	NDA
PREZISTA	darunavir	TABLET, FILM COATED	NDA
PREZISTA	darunavir	TABLET, FILM COATED	NDA
PREZISTA	darunavir	TABLET, FILM COATED	NDA
PREZISTA	darunavir	SUSPENSION	NDA
PREZISTA	darunavir	TABLET, FILM COATED	NDA
PROCRIT	Erythropoietin	INJECTION, SOLUTION	BLA
PROCRIT	Erythropoietin	INJECTION, SOLUTION	BLA
PROCRIT	Erythropoietin	INJECTION, SOLUTION	BLA
PROCRIT	Erythropoietin	INJECTION, SOLUTION	BLA
PROCRIT	Erythropoietin	INJECTION, SOLUTION	BLA
PROCRIT	Erythropoietin	INJECTION, SOLUTION	BLA
PROCRIT	Erythropoietin	INJECTION, SOLUTION	BLA
-	Polyethylene Glycol 400	SOLUTION	DRUG FOR FURTHER PROCESSING
REMICADE	INFLIXIMAB	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	BLA
RISPERDAL	risperidone	TABLET	NDA
RISPERDAL	risperidone	TABLET	NDA
RISPERDAL	risperidone	SOLUTION	NDA
RISPERDAL	risperidone	TABLET	NDA
RISPERDAL	risperidone	TABLET	NDA
RISPERDAL	risperidone	TABLET	NDA
RISPERDAL CONSTA	risperidone	KIT	NDA
RISPERDAL CONSTA	risperidone	KIT	NDA
RISPERDAL CONSTA	risperidone	KIT	NDA
RISPERDAL CONSTA	risperidone	KIT	NDA
RISPERDAL M-TAB	risperidone	TABLET, ORALLY DISINTEGRATING	NDA
RISPERDAL M-TAB	risperidone	TABLET, ORALLY DISINTEGRATING	NDA
RISPERDAL M-TAB	risperidone	TABLET, ORALLY DISINTEGRATING	NDA
RISPERDAL M-TAB	risperidone	TABLET, ORALLY DISINTEGRATING	NDA
RISPERDAL M-TAB	risperidone	TABLET, ORALLY DISINTEGRATING	NDA
-	Rilpivirine	POWDER	BULK INGREDIENT
-	Risperidone	POWDER	BULK INGREDIENT
Risperidone	risperidone	SOLUTION	NDA
Rybrevant	amivantamab-vmjw	INJECTION	BLA
Rybrevant Faspro	AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)	INJECTION	BLA
Rybrevant Faspro	AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)	INJECTION	BLA
Rybrevant Faspro	AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)	INJECTION	BLA
Rybrevant Faspro	AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)	INJECTION	BLA
SIMPONI ARIA	golimumab	SOLUTION	BLA
SIRTURO	Bedaquiline Fumarate	TABLET	NDA
SIRTURO	Bedaquiline Fumarate	TABLET	NDA
SPORANOX	ITRACONAZOLE	CAPSULE	NDA
STELARA	ustekinumab	INJECTION, SOLUTION	BLA
STELARA	ustekinumab	INJECTION, SOLUTION	BLA
Simponi	golimumab	INJECTION, SOLUTION	BLA
Simponi	golimumab	INJECTION, SOLUTION	BLA
Spravato	Esketamine Hydrochloride	SOLUTION	NDA
Stelara	ustekinumab	SOLUTION	BLA
Symtuza	Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide	TABLET, FILM COATED	NDA
TALVEY	talquetamab	INJECTION	BLA
TALVEY	talquetamab	INJECTION	BLA
TECVAYLI	teclistamab-cqyv	INJECTION	BLA
TECVAYLI	teclistamab-cqyv	INJECTION	BLA
TREMFYA	Guselkumab	INJECTION	BLA
TREMFYA	Guselkumab	INJECTION	BLA
TREMFYA	guselkumab	INJECTION	BLA
Topamax	topiramate	TABLET, COATED	NDA
Topamax	topiramate	TABLET, COATED	NDA
Topamax	topiramate	TABLET, COATED	NDA
Topamax	topiramate	TABLET, COATED	NDA
Topamax	topiramate	CAPSULE, COATED PELLETS	NDA
Topamax	topiramate	CAPSULE, COATED PELLETS	NDA
VERMOX	mebendazole	TABLET, CHEWABLE	NDA
XARELTO	rivaroxaban	TABLET, FILM COATED	NDA
XARELTO	Rivaroxaban	KIT	NDA
Xarelto	rivaroxaban	GRANULE, FOR SUSPENSION	NDA
Xarelto	rivaroxaban	TABLET, FILM COATED	NDA
Xarelto	rivaroxaban	TABLET, FILM COATED	NDA
Xarelto	rivaroxaban	TABLET, FILM COATED	NDA
YONDELIS	Trabectedin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	NDA
Zytiga	abiraterone acetate	TABLET	NDA
Zytiga	Abiraterone acetate	TABLET, FILM COATED	NDA
ustekinumab	ustekinumab	INJECTION, SOLUTION	BLA
ustekinumab	ustekinumab	INJECTION, SOLUTION	BLA
ustekinumab	ustekinumab	SOLUTION	BLA

Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.